Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Operating Leases (2020 - 2025)

Q32 Bio (QTTB) has 6 years of Operating Leases data on record, last reported at $5.1 million in Q3 2025.

  • For Q3 2025, Operating Leases changed N/A year-over-year to $5.1 million; the TTM value through Sep 2025 reached $5.1 million, changed N/A, while the annual FY2024 figure was $5.6 million, 9.8% down from the prior year.
  • Operating Leases reached $5.1 million in Q3 2025 per QTTB's latest filing, down from $5.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $28.3 million in Q3 2022 and bottomed at $5.1 million in Q3 2025.
  • Average Operating Leases over 5 years is $17.8 million, with a median of $23.5 million recorded in 2022.
  • Peak YoY movement for Operating Leases: surged 144.67% in 2022, then crashed 77.8% in 2024.
  • A 5-year view of Operating Leases shows it stood at $23.7 million in 2021, then increased by 17.85% to $27.9 million in 2022, then tumbled by 77.62% to $6.2 million in 2023, then fell by 9.8% to $5.6 million in 2024, then fell by 9.14% to $5.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $5.1 million in Q3 2025, $5.6 million in Q4 2024, and $6.1 million in Q1 2024.